With apologies to Worthind, who was right on the money, there is a meeting coming up with the FDA. The meeting is for a number of things - only some of which I know. One is the possibility of getting ATC to market more quickly by reducing the number of patients needed. Of further interest, the trial is unblinded to the FDA but still blinded to Avexa. The FDA has all the trial data provided to the Drug Monitoring Safety Board (DMSB) and by the time of the meeting (probably already) the FDA will have the DSMB's full recommendations and report. Again, credit to Worthind on this. Not sure when the meeting is.
- Forums
- ASX - By Stock
- AVX
- potentially important times
potentially important times, page-18
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MTL
Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares